OCTA in in Mild Cognitive Impairment and Alzheimer's Disease - Clinical Trial

What is the Purpose of this Study?

We are doing this study learn more about how we can identify potential biomarkers in your eyes that may let us predict and/or diagnose one or more illness or condition.

Although we will not be able to make these diagnoses now, one day in the future we may be able to use the information we have learned now to make these diagnoses in other people in the future:
-Alzheimer’s disease
-Mild cognitive impairment
-Parkinson’s disease
-Frontotemporal dementia
-Dementia of Lewy body
-Multiple sclerosis
-Traumatic Brain Injury
-PTSD
-ALS
-Huntington’s
-Down syndrome

What is the Condition Being Studied?

Alzheimers Disease, Mild Cognitive Impairment and Parkinson's disease

Who Can Participate in the Study?

Adults being seen in any Duke Clinic with:
-Alzheimer’s disease
-Mild cognitive impairment
-Parkinson’s disease
-Frontotemporal dementia
-Dementia of Lewy body
-Multiple sclerosis
-Traumatic brain injury
-PTSD
-ALS
-Huntington’s
-Down syndrome

People in a wheelchair or with a head tremor or prior retinal surgery would not be eligible.

Age Group
Adults

What is Involved?

If you choose to join this study, you will:
-Come to the Morreene Road clinic for 30 minutes
-Have images taken of your eyes
-Have your vision checked
-Complete a questionnaire

*No one will touch your eye and no drops will be used.

For more information about this study, please visit us at:
https://dukeeyecenter.duke.edu/research/research-laboratories/duke-neur…

Study Details

Full Title
Evaluating the Retinal Microvasculature in Mild Cognitive Impairment and Alzheimer's Disease using Optical Coherence Tomography Angiography
Principal Investigator
Ophthalmologist
Protocol Number
IRB: PRO00082598
NCT: NCT03233646
Phase
Phase N/A
ClinicalTrials.gov
Enrollment Status
Open for Enrollment
Participate
Contact the Duke Recruitment Innovation Center
MyResearchPartners@duke.edu
or
919-681-5698